Reform of the food regulatory system
In March 2020, the Australian New Zealand Ministerial Forum on Food Regulation (the Forum) endorsed an implementation plan for an ambitious reform agenda for the food regulatory system aimed at ensuring the system remains strong, robust and agile into...More
The Australian Technical Advisory Group on Immunisation (ATAGI) is consulting with stakeholders on proposed changes to rabies vaccination recommendations for inclusion in the Australian Immunisation Handbook, with an intention to submit the recommendation to the National Health and Medical...More
The Australian Government is working towards zero suicides and appointed Ms Christine Morgan as the first National Suicide Prevention Adviser reporting directly to the Prime Minister.
The National Suicide Prevention Adviser has provided the Prime Minister with the...More
The Australian Government welcomes the Productivity Commission (PC) Inquiry Report on Mental Health. It provides 21 recommendations with 103 associated actions spanning five key themes:
prevention and early help for people;
improve people’s experiences with mental...More
Changes to the Australian Immunisation Register legislation
We're seeking feedback on proposed changes to the Australian Immunisation Register Act 2015 (AIR Act).
The proposed amendment to the AIR Act is to make it mandatory for all recognised vaccination...More
Interim decision to amend the current Poisons Standard in relation to nicotine, Joint ACMS-ACCS meeting #25, June 2020
This consultation is for an interim decision to amend the scheduling of nicotine in the current Poisons Standard, following advice sought at the 23 June 2020 meeting of...More
Background
In January 2020, the Minister for Health, the Hon Greg Hunt MP, released the Interim Advice from the National Dust Disease Taskforce. A copy of the Interim Advice and Minister’s media release can be found under Related Documents.
Why we are...More
The Department of Health through the Office of Drug Control (ODC) is seeking comments from interested parties on a review of the structure, design and administrative processes for medicinal cannabis related permits (the review).
This review is part of the broader reforms being...More
Since 2002, Aboriginal and Torres Strait Islander people have been able to have their status recorded confidentially on a database called the Voluntary Indigenous Identifier (VII).
The VII is primarily used to estimate use of the Medicare Benefits Scheme by Aboriginal and Torres Strait...More
From 19 October 2020, how the TGA engages with the sponsors for post market reviews has changed. A new medical device Post Market Review Compliance Dashboard has been developed in TBS to respond to post market reviews. The new compliance dashboard will provide the sponsors with an efficient...More
In March 2020, the Australian New Zealand Forum on Food Regulation (the Forum) endorsed an implementation plan for an ambitious reform agenda for the food regulatory system aimed at ensuring the system remains strong, robust and agile into the future. The reform agenda is being progressed through...More
On 14 August 2020, the Hon Mark Coulton, Minister for Regional Health, Regional Communications and Local Government, announced a review into the Hearing Services Program.
An Independent Panel made up of Professor Mike Woods (Chair) and Dr Zena Burgess will conduct the Review, with the...More
The Therapeutic Goods Administration (TGA) cost recovers the cost of activities associated with the registration and listing of medicines and inclusion of medical devices, including in vitro diagnostic (IVD) devices, and biologicals onto the Australian Register of Therapeutic Goods (ARTG) and...More
Thank you for your interest in becoming accredited as a service provider for the Australian Government Hearing Services Program.
Please click the link below to begin your application.
You may wish to download a PDF of the application form for your information before you proceed....More
We are seeking your views on the Australian Government’s National Bowel Cancer Screening Program (the Program).
The Department of Health has commissioned an independent and comprehensive review of the Program. The Review will measure the extent to which the program is meeting its...More
On 7 April 2019, the Minister for Health announced an updated review of natural therapies . The Minister recently agreed the review will now be led by the Australian Government Deputy Chief Medical Officer (Deputy CMO), Professor Michael Kidd. The Deputy CMO will continue to be...More
Review of the My Health Records legislation
We're seeking feedback on how we can improve the legislation that underpins the My Health Record system.
This is part of a review to improve the legislation, including to:
better support...More
The Australian Radiation Protection and Nuclear Safety Agency (ARPANSA) is the Australian Government’s primary authority on radiation protection and nuclear safety. We protect the Australian people and the environment from the harmful effects of radiation through understanding risks, best...More
The Australian Government is undertaking a significant program to reform the regulation of therapeutic goods in Australia. As part of the Australian Government Department of Health, the Therapeutic Goods Administration (TGA) regulates therapeutic goods, and is responsible for implementing the...More
Scheduling amendments referred to expert advisory committee
This consultation is for interim decisions made in relation to applications and delegate initiated proposals to amend the scheduling in the Poisons Standard, following advice sought at the 23-25 June 2020 meetings of ...More
The Medical Services Advisory Committee (MSAC) is an independent scientific committee, established by the Minister for Health in 1998. The committee comprises individuals with expertise in clinical medicine, health economics and consumer matters.
MSAC evaluates medical services,...More
We know the importance of investing in Australia’s young people, and believe in their power to create positive change.
For us to achieve meaningful change now and into the future, we must involve young people in the decisions that affect them.
To inform the development of the...More
Consistent with the Medical Research Future Fund Act 2015 (the Act), the independent Australian Medical Research Advisory Board (AMRAB) is conducting a consultation to develop the Medical Research Future Fund (MRFF) Australian Medical Research and Innovation Priorities...More
The current guidance Compounded medicines and good manufacturing practice (GMP) was developed in relation to the PIC/S Guide to GMP for Medicinal Products PE-009-8 15 January 2009, following public consultation in 2015. This document provides guidance on the interpretation of the PIC/S Guide to...More
The Program
The Department of Health (the Department) has recently commissioned a review of t he Medical Treatment Overseas Program (MTOP) which is being undertaken by Aspex Consulting with Dr Ruth Vine as the lead.
To support this review, Aspex Consulting are keen...More
Informing the National Preventive Health Strategy
Preventive health is a key pillar of Australia’s Long Term National Health Plan.
As announced by the Minister for Health, the Hon Greg Hunt MP in June 2019 , the Australian Government is developing a 10-year National Preventive...More
The Australian Government is undertaking a significant program of reform to the regulation of therapeutic goods in Australia. As part of the Australian Government Department of Health, the Therapeutic Goods Administration (TGA) regulates therapeutic goods, and is responsible for implementing...More
The Australian Government is undertaking a significant program to reform the regulation of therapeutic goods in Australia. As part of the Australian Government Department of Health, the Therapeutic Goods Administration (TGA) regulates therapeutic goods, and is responsible for implementing...More
The Australian Government is undertaking a significant program to reform the regulation of therapeutic goods in Australia. As part of the Australian Government Department of Health, the Therapeutic Goods Administration (TGA) regulates therapeutic goods, and is responsible for implementing the...More
This form should be used by manufacturers and sponsors of medical devices that record patient images or that are anatomical models, and that will be reclassified by the amendments to the Therapeutic Goods (Medical Devices) Regulations 2002 from 25 February 2021. Devices are eligible for...More